Get the Stockscreener App
3.75
8.70%
0.30
After Hours:
3.75
Heartsciences Inc stock is traded at $3.75, with a volume of 46,559.
It is up +8.70% in the last 24 hours and up +2.74% over the past month.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
See More
Previous Close:
$3.45
Open:
$3.46
24h Volume:
46,559
Relative Volume:
1.64
Market Cap:
$3.68M
Revenue:
-
Net Income/Loss:
$-7.29M
P/E Ratio:
-0.1539
EPS:
-24.3686
Net Cash Flow:
$-6.81M
1W Performance:
+13.64%
1M Performance:
+2.74%
6M Performance:
+13.64%
1Y Performance:
-71.04%
1-Day Range:
$3.45
$3.9368
1-Week Range:
$3.10
$3.9368
52-Week Range:
$2.36
$18.50
Heartsciences Inc Stock (HSCS) Company Profile
Name
Heartsciences Inc
Sector
Industry
Phone
682-237-7781
Address
550 RESERVE ST, SUITE 360, SOUTHLAKE
Compare HSCS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HSCS
Heartsciences Inc
|
3.75 | 3.68M | 0 | -7.29M | -6.81M | -24.37 |
|
ABT
Abbott Laboratories
|
128.22 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.02 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
396.07 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.82 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
70.99 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Heartsciences Inc Stock (HSCS) Latest News
HeartSciences grants stock options to executives and directors - MSN
HeartSciences grants stock options to executives and directors By Investing.com - Investing.com South Africa
HeartSciences Inc. withdraws IPO registration - Investing.com
HeartSciences Inc. withdraws IPO registration By Investing.com - Investing.com UK
HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results - The Manila Times
HeartSciences Advances AI-Powered ECG Platform, FDA Submission Set for Q1 2025 - StockTitan
David Chung Lands Top Job at Heart Repair Technologies - MPO-mag
HeartSciences' AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement - The Manila Times
HeartSciences’ AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement - GlobeNewswire
HeartSciences Secures $125 Medicare Reimbursement for AI-ECG Tech, Awaits FDA Nod | HSCSW Stock News - StockTitan
HeartSciences shareholders approve auditor and meeting adjournment - Investing.com India
HeartSciences shareholders approve auditor and meeting adjournment By Investing.com - Investing.com UK
Contrasting Heart Test Laboratories (NASDAQ:HSCS) and Bone Biologics (NASDAQ:BBLG) - Defense World
Heart Test Laboratories announces corporate name change to HeartSciences - Investing.com India
Heart Test Laboratories (NASDAQ:HSCS) Stock Price Down 10.9% – Time to Sell? - Defense World
HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit - The Manila Times
Mobile Cardiac Telemetry Systems Market Players In Latest Report - WhaTech
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.34% - MSN
Heart Test Laboratories, Inc. (NASDAQ:HSCS) Short Interest Update - Defense World
A new trading data show Heart Test Laboratories Inc. (HSCS) is showing positive returns. - SETE News
Heart Test Laboratories Inc. [HSCS] is -75.15% lower this YTD. Is it still time to buy? - The DBT News
3 Penny Stocks to Watch Now, 9/25/24 - MSN
"Nasdaq Stocks Set for Explosive Growth: BNZI, SEEL, PRSO, MSS, HSCS Revamp for Big Potential" - WICZ
Heart Test Laboratories Inc. (HSCS) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
Is Heart Test Laboratories Inc. (HSCS) a good investment opportunity? - US Post News
Pre-market Movers: MSS, HSCS, BIVI, GBNY, LBRDK… - RTTNews
Insider’s View: Deciphering Heart Test Laboratories Inc. (HSCS)’s Financial Health Through Ratios - The Dwinnex
Why Maison Solutions Shares Are Trading Higher By Around 91%; Here Are 20 Stocks Moving Premarket - Benzinga
Heart Test Laboratories’ (HSCS) Buy Rating Reaffirmed at Ascendiant Capital Markets - Defense World
Heart Test Laboratories, Inc. (NASDAQ:HSCS) Short Interest Down 11.8% in August - Defense World
Heart Test (HSCS) Stock Gains After-Market Following Volatile Trading - Stocks Telegraph
Shares of HeartSciences get a bump from announcement of non-dilutive financing - Kursiv Media
Closing Bell Recap: Heart Test Laboratories Inc. (HSCS) Ends at 2.79, Reflecting a -1.06 Downturn - The Dwinnex
HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results - ForexTV.com
How analysts predict Heart Test Laboratories Inc. (HSCS) will perform this quarter? - US Post News
HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission - StockTitan
Heart Test Laboratories (NASDAQ:HSCS) Shares Down 13% - Defense World
HSCS stock touches 52-week low at $3.01 amid sharp annual decline - Investing.com Australia
Heart Test Laboratories, Inc. announced that it expects to receive $2.01 million in funding - Marketscreener.com
Heart Test Labs extends loan maturity to 2025 - Investing.com
Heart Test Laboratories (NASDAQ:HSCS) Stock Price Up 9.2% - Defense World
Heart Test Labs stock target cut by two thirds, maintains buy - Investing.com Canada
HeartSciences reports fiscal 2024 financial results - Medical Buyer
Innovation Value Institute Analysis Demonstrates - GlobeNewswire
HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare - GlobeNewswire
HeartSciences Adds Another International Patent To Its IP Portfolio - MPO-mag
HeartSciences Adds Another International Patent to its IP Portfolio - MPO-mag
Doctors Say Providence’s Sale of Its Hospitals’ Testing Labs Has Endangered Patients - Willamette Week
HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction - BioSpace
HeartSciences Announces Allowance of U.S Patent for AI-ECG - GlobeNewswire
Heartsciences Inc Stock (HSCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.14%
2.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):